ADRB2 |
adrenoceptor beta 2 |
- Adrenoceptors
- G alpha (s) signalling events
- Ub-specific processing proteases
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- ADORA2B mediated anti-inflammatory cytokines production
|
- Spermine
- Amphetamine
- Betaxolol
- Bethanidine
- Isoetarine
- Cabergoline
- Metoprolol
- Amitriptyline
- Olanzapine
- Atenolol
- Norepinephrine
- Mirtazapine
- Timolol
- Phenylpropanolamine
- Dipivefrin
- Sotalol
- Carteolol
- Nortriptyline
- Propranolol
- Labetalol
- Bisoprolol
- Epinephrine
- Trimipramine
- Orciprenaline
- Dobutamine
- Pseudoephedrine
- Alprenolol
- Ritodrine
- Terbutaline
- Bitolterol
- Phenoxybenzamine
- Salmeterol
- Pindolol
- Formoterol
- Salbutamol
- Isoprenaline
- Arbutamine
- Carvedilol
- Desipramine
- Propafenone
- Acebutolol
- Nadolol
- Levobunolol
- Metipranolol
- Arformoterol
- Fenoterol
- Pirbuterol
- Bevantolol
- Penbutolol
- Ephedra
- Mephentermine
- Procaterol
- Clenbuterol
- Bambuterol
- Oxprenolol
- Putrescine
- Spermidine
- Celiprolol
- Nebivolol
- Indacaterol
- NCX 950
- Asenapine
- Droxidopa
- Bufuralol
- (2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol
- Bopindolol
- Bupranolol
- Befunolol
- Olodaterol
- Vilanterol
- Tulobuterol
- Levosalbutamol
|
|
AP2S1 |
adaptor related protein complex 2 subunit sigma 1 |
- Nef Mediated CD4 Down-regulation
- Retrograde neurotrophin signalling
- Retrograde neurotrophin signalling
- Nef Mediated CD8 Down-regulation
- MHC class II antigen presentation
- EPH-ephrin mediated repulsion of cells
- Recycling pathway of L1
- Recycling pathway of L1
- WNT5A-dependent internalization of FZD4
- WNT5A-dependent internalization of FZD2, FZD5 and ROR2
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- VLDLR internalisation and degradation
- LDL clearance
|
|
|
APP |
amyloid beta precursor protein |
- Platelet degranulation
- ECM proteoglycans
- Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
- G alpha (q) signalling events
- G alpha (i) signalling events
- Lysosome Vesicle Biogenesis
- Formyl peptide receptors bind formyl peptides and many other ligands
- TAK1 activates NFkB by phosphorylation and activation of IKKs complex
- The NLRP3 inflammasome
- Advanced glycosylation endproduct receptor signaling
- Advanced glycosylation endproduct receptor signaling
- Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
- Post-translational protein phosphorylation
- TRAF6 mediated NF-kB activation
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
- Purinergic signaling in leishmaniasis infection
- Amyloid fiber formation
|
- Deferoxamine
- Aluminium
- Zinc
- L-methionine (R)-S-oxide
- Resveratrol
- Phenserine
- Tiomolibdate ion
- CAD106
- Mito-4509
- Dimercaprol
- Copper
- Florbetaben (18F)
- Florbetapir (18F)
- Flutemetamol (18F)
|
|
ARL6IP4 |
ADP ribosylation factor like GTPase 6 interacting protein 4 |
|
|
|
ASB6 |
ankyrin repeat and SOCS box containing 6 |
- Neddylation
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
BIRC6 |
baculoviral IAP repeat containing 6 |
|
|
|
C1orf109 |
chromosome 1 open reading frame 109 |
|
|
|
ERBB3 |
erb-b2 receptor tyrosine kinase 3 |
|
|
- Lethal congenital contractural syndrome (LCCS)
- Type I diabetes mellitus
|
ERBB4 |
erb-b2 receptor tyrosine kinase 4 |
|
|
|
GDF11 |
growth differentiation factor 11 |
|
|
|
IRS4 |
insulin receptor substrate 4 |
- IRS-related events triggered by IGF1R
|
|
|
ISCA2 |
iron-sulfur cluster assembly 2 |
- Mitochondrial iron-sulfur cluster biogenesis
|
|
|
KDM3B |
lysine demethylase 3B |
- HDMs demethylate histones
|
|
|
LEPR |
leptin receptor |
|
|
|
LZTS2 |
leucine zipper tumor suppressor 2 |
|
|
|
MAGEL2 |
MAGE family member L2 |
|
|
|
MARK2 |
microtubule affinity regulating kinase 2 |
|
|
|
MNAT1 |
MNAT1 component of CDK activating kinase |
- Formation of RNA Pol II elongation complex
- Formation of the Early Elongation Complex
- Formation of HIV elongation complex in the absence of HIV Tat
- Formation of the HIV-1 Early Elongation Complex
- RNA Pol II CTD phosphorylation and interaction with CE during HIV infection
- HIV Transcription Initiation
- RNA Polymerase II HIV Promoter Escape
- Transcription of the HIV genome
- Formation of HIV-1 elongation complex containing HIV-1 Tat
- Tat-mediated elongation of the HIV-1 transcript
- NoRC negatively regulates rRNA expression
- Formation of Incision Complex in GG-NER
- RNA Polymerase II Pre-transcription Events
- Formation of TC-NER Pre-Incision Complex
- Transcription-Coupled Nucleotide Excision Repair (TC-NER)
- Dual incision in TC-NER
- Gap-filling DNA repair synthesis and ligation in TC-NER
- TP53 Regulates Transcription of DNA Repair Genes
- Cyclin E associated events during G1/S transition
- Cyclin D associated events in G1
- Cyclin A/B1/B2 associated events during G2/M transition
- Cyclin A:Cdk2-associated events at S phase entry
- mRNA Capping
- RNA Polymerase I Transcription Initiation
- RNA Polymerase I Promoter Escape
- RNA Polymerase II Promoter Escape
- RNA Polymerase II Transcription Pre-Initiation And Promoter Opening
- RNA Polymerase I Transcription Termination
- RNA Polymerase II Transcription Initiation
- RNA Polymerase II Transcription Elongation
- RNA Polymerase II Transcription Initiation And Promoter Clearance
- RNA Pol II CTD phosphorylation and interaction with CE
- RUNX1 regulates transcription of genes involved in differentiation of HSCs
|
|
|
MTNR1A |
melatonin receptor 1A |
- Class A/1 (Rhodopsin-like receptors)
- G alpha (i) signalling events
|
- Ramelteon
- Melatonin
- Resveratrol
- Agomelatine
- Tasimelteon
|
|
MTNR1B |
melatonin receptor 1B |
- Class A/1 (Rhodopsin-like receptors)
- G alpha (i) signalling events
|
- Ramelteon
- Melatonin
- Resveratrol
- Agomelatine
- Tasimelteon
|
- Type II diabetes mellitus
|
NEUROD4 |
neuronal differentiation 4 |
|
|
|
ORMDL2 |
ORMDL sphingolipid biosynthesis regulator 2 |
- Sphingolipid de novo biosynthesis
|
|
|
PPP1R1A |
protein phosphatase 1 regulatory inhibitor subunit 1A |
|
|
|
RFC4 |
replication factor C subunit 4 |
- Translesion synthesis by REV1
- Recognition of DNA damage by PCNA-containing replication complex
- Translesion Synthesis by POLH
- Polymerase switching on the C-strand of the telomere
- Activation of ATR in response to replication stress
- PCNA-Dependent Long Patch Base Excision Repair
- Translesion synthesis by POLK
- Translesion synthesis by POLI
- Termination of translesion DNA synthesis
- HDR through Single Strand Annealing (SSA)
- HDR through Homologous Recombination (HRR)
- Processing of DNA double-strand break ends
- Presynaptic phase of homologous DNA pairing and strand exchange
- Gap-filling DNA repair synthesis and ligation in GG-NER
- Dual Incision in GG-NER
- Dual incision in TC-NER
- Gap-filling DNA repair synthesis and ligation in TC-NER
- Regulation of TP53 Activity through Phosphorylation
- Polymerase switching
- G2/M DNA damage checkpoint
|
|
|
RNF166 |
ring finger protein 166 |
|
|
|
RRM2B |
ribonucleotide reductase regulatory TP53 inducible subunit M2B |
- Interconversion of nucleotide di- and triphosphates
- TP53 Regulates Metabolic Genes
|
|
- Mitochondrial DNA depletion syndrome (MDS)
|
SUOX |
sulfite oxidase |
- Sulfide oxidation to sulfate
|
- (Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)
|
|
TBATA |
thymus, brain and testes associated |
|
|
|
TRIM32 |
tripartite motif containing 32 |
- Regulation of innate immune responses to cytosolic DNA
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
- Bardet-Biedl syndrome (BBS)
|
TRIM8 |
tripartite motif containing 8 |
- Interferon gamma signaling
|
|
|
TSG101 |
tumor susceptibility 101 |
- Budding and maturation of HIV virion
- Membrane binding and targetting of GAG proteins
- Endosomal Sorting Complex Required For Transport (ESCRT)
- HCMV Late Events
- Late endosomal microautophagy
|
|
|
UBASH3A |
ubiquitin associated and SH3 domain containing A |
|
|
|
UBASH3B |
ubiquitin associated and SH3 domain containing B |
|
|
|
UBE2D3 |
ubiquitin conjugating enzyme E2 D3 |
- Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha
- TICAM1, RIP1-mediated IKK complex recruitment
- Signaling by BMP
- Downregulation of SMAD2/3:SMAD4 transcriptional activity
- E3 ubiquitin ligases ubiquitinate target proteins
- Neddylation
- Peroxisomal protein import
- Negative regulators of DDX58/IFIH1 signaling
- IKK complex recruitment mediated by RIP1
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
UBE2K |
ubiquitin conjugating enzyme E2 K |
- Synthesis of active ubiquitin: roles of E1 and E2 enzymes
- Negative regulators of DDX58/IFIH1 signaling
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
UBE2U |
ubiquitin conjugating enzyme E2 U |
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
UBE2Z |
ubiquitin conjugating enzyme E2 Z |
- Synthesis of active ubiquitin: roles of E1 and E2 enzymes
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
USP8 |
ubiquitin specific peptidase 8 |
- Downregulation of ERBB2:ERBB3 signaling
- Regulation of FZD by ubiquitination
- Ub-specific processing proteases
- Negative regulation of MET activity
|
|
|
ZAP70 |
zeta chain of T cell receptor associated protein kinase 70 |
- Translocation of ZAP-70 to Immunological synapse
- Generation of second messenger molecules
|
|
- Combined immunodeficiencies (CIDs), including the following nine diseases: X-linked hyper IgM syndrome; CD40 deficiency hyper IgM syndrome; Purine nucleoside phosphorylase (PNP) deficiency; Omenn syndrome; MHC deficiency (HLA-class I); MHC deficiency (HLA-class II); Zap-70 deficiency; p56 Lck deficiency; CD8 deficiency
|